Avantor (AVTR) Non-Current Assets (2018 - 2026)
Avantor's (AVTR) quarterly Non-Current Assets came in at $9.3 billion in Q1 2026, down 7.82% year-on-year from $10.0 billion in Q1 2025, and down 0.91% quarter-over-quarter from $9.3 billion in Q4 2025.
Avantor (AVTR) Non-Current Assets (2018 - 2026) Analysis & Trends
Avantor's Non-Current Assets history runs 9 years deep, the most recent figure standing at $9.3 billion for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 7.82% year-over-year to $9.3 billion in Q1 2026; TTM through Mar 2026 was $38.3 billion, a 5.97% decrease from a year earlier, with the FY2025 full-year figure at $9.3 billion, down 6.26% from the prior year.
- Non-Current Assets slipped to $9.3 billion in Q1 2026 per AVTR's latest filing, from $9.3 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $11.2 billion in Q1 2022 and bottomed at $2.6 billion in Q4 2022.
- The 5-year median for Non-Current Assets is $10.3 billion (2024), against an average of $9.4 billion.
- Across the five-year window, Non-Current Assets surged 179.07% in 2024 and slipped 8.87% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $2.6 billion in 2022, then jumped by 37.66% to $3.6 billion in 2023, then jumped by 179.07% to $10.0 billion in 2024, then decreased by 6.26% to $9.3 billion in 2025, then dropped by 0.91% to $9.3 billion in 2026.
- Per Business Quant, the three latest AVTR Non-Current Assets figures stand at $9.3 billion (Q1 2026), $9.3 billion (Q4 2025), and $9.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | 9.26 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.26 Bn |
| Dec 31, 2025 | 9.34 Bn |
| Sep 30, 2025 | 9.42 Bn |
| Jun 30, 2025 | 10.26 Bn |
| Mar 31, 2025 | 10.04 Bn |
| Dec 31, 2024 | 9.97 Bn |
| Sep 30, 2024 | 10.34 Bn |
| Jun 30, 2024 | 10.36 Bn |
| Mar 31, 2024 | 10.44 Bn |
| Dec 31, 2023 | 3.57 Bn |
| Sep 30, 2023 | 10.41 Bn |
| Jun 30, 2023 | 10.56 Bn |
| Mar 31, 2023 | 10.77 Bn |
| Dec 31, 2022 | 2.59 Bn |
| Sep 30, 2022 | 10.55 Bn |
| Jun 30, 2022 | 10.86 Bn |
| Mar 31, 2022 | 11.23 Bn |
| Dec 31, 2021 | 2.38 Bn |
| Sep 30, 2021 | 8.63 Bn |
| Jun 30, 2021 | 8.83 Bn |